Hyloris Pharmaceuticals S.A.
HYL.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€6 | -€15 | -€11 | -€12 |
| Dep. & Amort. | €1 | €0 | €0 | €0 |
| Deferred Tax | €0 | -€0 | €0 | €0 |
| Stock-Based Comp. | -€1 | €1 | €1 | €1 |
| Change in WC | -€1 | €2 | -€3 | -€1 |
| Other Non-Cash | €0 | -€0 | €0 | €0 |
| Operating Cash Flow | -€7 | -€13 | -€13 | -€11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€0 | -€0 | -€1 | -€1 |
| Net Acquisitions | €0 | €0 | €0 | -€1 |
| Inv. Purchases | €0 | €0 | -€1 | -€1 |
| Inv. Sales/Matur. | €0 | €10 | €1 | €0 |
| Other Inv. Act. | €0 | €0 | -€1 | €0 |
| Investing Cash Flow | €0 | €10 | -€1 | -€3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€0 | €0 | -€7 | -€0 |
| Stock Issued | €0 | €0 | €17 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€0 | -€0 | -€2 | €0 |
| Financing Cash Flow | -€0 | -€0 | €8 | -€0 |
| Forex Effect | €0 | -€0 | €0 | €0 |
| Net Chg. in Cash | -€7 | -€3 | -€7 | -€14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €30 | €33 | €50 | €64 |
| End Cash | €24 | €30 | €43 | €50 |
| Free Cash Flow | -€7 | -€13 | -€14 | -€12 |